Durable Viral Suppression Among People Living with HIV who Inject Drugs from a Community-Based Cohort in Baltimore, Maryland, 1997-2017.
People who inject drugs (PWID) face disparities in HIV treatment outcomes and may be less likely to achieve durable viral suppression. We characterized transitions in and out of viral suppression from 1997-2017 in a long-standing community-based cohort of PWID (AIDS Linked to the IntraVenous Experience (ALIVE)) among HIV+ participants with a study visit in or after 1997. Transition probabilities were defined between four states: 1) suppressed; 2) detectable; 3) lost-to-follow-up; 4) dead. We used multinomial logistic regression analysis to examine factors associated with transition probabilities with a focus on transitions from suppression. Among 1,061 participants, the median age was 44, 32% were female, 93% were African-American, 59% had recently injected drugs and 28% were virologically suppressed at baseline. Significant improvements in durable viral suppression were observed over time, however death rates remained relatively stable. In adjusted analysis, injection drug use and homelessness were associated with increased virological rebound in earlier time periods, while only age and race were associated with virological rebound in 2012-2017. Opioid use was associated with an increased risk of death following suppression in 2012-2017. Despite significant improvements in durable viral suppression, sub-groups of PWID may need additional efforts to maintain viral suppression and prevent premature mortality.